Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is REX REX stock ready for a move today REX notches 23 pct EPS beat vs analyst estimates Fox Corporation FOX Options Volatility Signals Divergent Market Expectations Ahead of Fiscal Q3 2026 Earnings Release The steady strength in Allied Gaming AGAE story Rallies 20260506 Claritev CTEV Stock Is It Forming a Reversal Q4 2025 Earnings Underperform Scope for Meaningful Rate Cuts Ahead Says Credit Suisses Neelkanth Mishra US Stocks Edge Higher as Chip Rally Continues Micron Surges 9 on AI Optimism Traders Debate Potential Shift Away from Quarterly Earnings Reporting Nio Shares Surge on Launch of First Flagship SUV in Over Two Years Snowflake Stock Surges 36 on Earnings Beat and 6 Billion AWS Expansion Plan UK Exports to US Plunge 25 Following Trump Tariff Blitz NP Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Gains PATH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction CMDB Q1 2026 Earnings Positive EPS Amid Quiet Market Reaction Mativ Holdings MATV Q1 2026 Earnings EPS Surge of 194 Surprise Despite Flat Revenue Outlook MAC Q1 2026 Earnings BottomLine Miss Weighs on Investor Sentiment DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure Arrive AI Inc ARAI Holds Near Support After Minor Decline ZenaTech ZENA Sees 382 Decline Tests Near Key Support at 132 Precigen Inc PGEN Tests Key Support as Bearish Pressure Persists Near 403 BILL Holdings Stock Slips as Market Weighs Growth Prospects Key Levels to Watch Corteva CTVA Gains 114 as Stock Approaches Key Resistance Levels Microbot Medical Inc MBOT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction IE Q1 2026 Earnings EPS Misses Estimates Widely as Exploration Continues SpaceX IPO Prospectus Highlights Starlinks Central Role in Revenue and Profit Growth Trump and Senate Republican Tensions Political Risks Could Shape Policy Outlook for Investors Pharming Group Q1 2026 Earnings Missed EPS Estimates Amid Operational Challenges PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026